TN2009000233A1 - Radiolabelling via fluorination of aziridines - Google Patents

Radiolabelling via fluorination of aziridines

Info

Publication number
TN2009000233A1
TN2009000233A1 TNP2009000233A TN2009000233A TN2009000233A1 TN 2009000233 A1 TN2009000233 A1 TN 2009000233A1 TN P2009000233 A TNP2009000233 A TN P2009000233A TN 2009000233 A TN2009000233 A TN 2009000233A TN 2009000233 A1 TN2009000233 A1 TN 2009000233A1
Authority
TN
Tunisia
Prior art keywords
radiolabelling
aziridines
via fluorination
fluorination
compounds
Prior art date
Application number
TNP2009000233A
Other languages
English (en)
Inventor
Ananth Srinivasan
Thomas Brumby
Timo Stellfeld
Keith Graham
Ulrike Rohn
Jessica Becaud
Linjing Mu
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP07090001A external-priority patent/EP1944288A1/fr
Priority claimed from EP07090079A external-priority patent/EP1985624A3/fr
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of TN2009000233A1 publication Critical patent/TN2009000233A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/001—Acyclic or carbocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/08—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/22—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • C07D203/24—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
TNP2009000233A 2007-01-09 2009-06-08 Radiolabelling via fluorination of aziridines TN2009000233A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07090001A EP1944288A1 (fr) 2007-01-09 2007-01-09 Radiomarquage par fluoration d'aziridines
EP07090079A EP1985624A3 (fr) 2007-04-23 2007-04-23 Procédé simple de radiofluorination de composés actifs biologiquement ou de biomolécules
PCT/EP2007/007968 WO2008083729A1 (fr) 2007-01-09 2007-09-07 Radiomarquage par fluoration d'aziridines

Publications (1)

Publication Number Publication Date
TN2009000233A1 true TN2009000233A1 (en) 2010-10-18

Family

ID=38941926

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2009000233A TN2009000233A1 (en) 2007-01-09 2009-06-08 Radiolabelling via fluorination of aziridines

Country Status (24)

Country Link
US (1) US20090022664A1 (fr)
EP (1) EP2099747A1 (fr)
JP (1) JP2010522140A (fr)
KR (1) KR20090096716A (fr)
AR (1) AR062856A1 (fr)
AU (1) AU2007343454A1 (fr)
BR (1) BRPI0720884A2 (fr)
CA (1) CA2674408A1 (fr)
CL (1) CL2007002673A1 (fr)
CO (1) CO6220852A2 (fr)
CR (1) CR10917A (fr)
DO (1) DOP2009000173A (fr)
EC (1) ECSP099505A (fr)
MA (1) MA31175B1 (fr)
MX (1) MX2009007395A (fr)
NO (1) NO20092813L (fr)
PA (1) PA8747801A1 (fr)
PE (1) PE20081661A1 (fr)
RU (1) RU2009130455A (fr)
SV (1) SV2009003328A (fr)
TN (1) TN2009000233A1 (fr)
TW (1) TW200829275A (fr)
UY (1) UY30594A1 (fr)
WO (1) WO2008083729A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8784774B2 (en) 2011-09-16 2014-07-22 General Electric Company Labeled molecular imaging agents and methods of use
US9468692B2 (en) 2014-01-23 2016-10-18 General Electric Company Labeled molecular imaging agents and methods of use
US9468693B2 (en) 2014-01-23 2016-10-18 General Electric Company Labeled molecular imaging agents and methods of use
NL2014828B1 (en) * 2015-05-20 2017-01-31 Out And Out Chemistry S P R L Method of performing a plurality of synthesis processes of preparing a radiopharmaceutical in series, a device and cassette for performing this method.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3954994A (en) * 1968-10-03 1976-05-04 Pfizer Inc. Intermediates for preparing hipolipemic agents and method of lowering the blood lipid level in mammals with said agents
JPS5810380B2 (ja) * 1975-01-31 1983-02-25 三共株式会社 ペプチドノ セイホウ
US6015790A (en) * 1997-10-06 2000-01-18 Basf Aktiengesellschaft Methods and compositions for treating rheumatoid arthritis
ATE453627T1 (de) * 1999-07-21 2010-01-15 Univ Pennsylvania Herstellung von verbindungen zur bestimmung der hypoxie
SE9903998D0 (sv) * 1999-11-03 1999-11-03 Astra Ab New compounds
US6894057B2 (en) * 2002-03-08 2005-05-17 Warner-Lambert Company Oxo-azabicyclic compounds
JP2006503008A (ja) * 2002-08-13 2006-01-26 ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー マトリクスメタロプロテイナーゼ阻害物質としての４−ヒドロキシキノリン誘導体
GB0222909D0 (en) * 2002-10-03 2002-11-13 Astrazeneca Ab Novel process and intermediates
US6875784B2 (en) * 2002-10-09 2005-04-05 Pharmacia & Upjohn Company Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives
CN1212307C (zh) * 2003-07-23 2005-07-27 中国科学院上海有机化学研究所 一种合成β－氟胺化合物的方法
CA2580461A1 (fr) * 2004-09-23 2006-04-06 Amgen Inc. Sulfonamidopropionamides substitues et procedes d'utilisation
JP2008535839A (ja) * 2005-04-07 2008-09-04 メルク エンド カムパニー インコーポレーテッド 有糸分裂キネシン阻害剤

Also Published As

Publication number Publication date
CR10917A (es) 2009-08-27
SV2009003328A (es) 2009-12-14
PE20081661A1 (es) 2009-01-18
AU2007343454A1 (en) 2008-07-17
ECSP099505A (es) 2009-08-28
BRPI0720884A2 (pt) 2014-03-25
UY30594A1 (es) 2008-09-02
JP2010522140A (ja) 2010-07-01
NO20092813L (no) 2009-09-22
MX2009007395A (es) 2009-07-17
US20090022664A1 (en) 2009-01-22
EP2099747A1 (fr) 2009-09-16
KR20090096716A (ko) 2009-09-14
MA31175B1 (fr) 2010-02-01
DOP2009000173A (es) 2010-10-31
CO6220852A2 (es) 2010-11-19
CL2007002673A1 (es) 2008-07-18
CA2674408A1 (fr) 2008-07-17
AR062856A1 (es) 2008-12-10
RU2009130455A (ru) 2011-02-20
WO2008083729A1 (fr) 2008-07-17
TW200829275A (en) 2008-07-16
PA8747801A1 (es) 2009-08-26

Similar Documents

Publication Publication Date Title
MX2009008430A (es) Anticuerpos anti-robo4 y sus usos.
TN2009000063A1 (en) Compounds and methods for 18f labeled agents
MX2009009291A (es) Compuestos activos biologicamente marcados con fluoro-benzoilo 18f como agentes de diagnostico por imagenes asi como precursores de benzotriazol-1-iloxi-benzoilo, 2,5-dioxo-pirrolidin-1-iloxi benzoilo y trimetilamonio benzoilo.
IL181529A (en) A method for radiofluorination, a compound containing radioactive fluorine and its use in the preparation of a radioactive drug
MX355181B (es) Anticuerpos humanos contra el factor tisular.
TN2010000213A1 (en) Wise binding antibodies and epitopes
MX2009008347A (es) Oxabicicloheptanos y oxabicicloheptenos, su preparacion y uso.
MX2011010295A (es) Reactivos de radiomarcado y metodos.
GB0520529D0 (en) Automated radiolabelling method
PH12013502194A1 (en) Antibodies to egfl7 and methods for their use
HRP20171443T1 (hr) Postupak za pripremanje jodiranog kontrastnog sredstva
MY155340A (en) Use of cathepsin c
MX2009003617A (es) Derivados de silicio para obtencion de imagenes por tomografia de emision de positrones (pet).
WO2009035959A3 (fr) Methodes de radiofluoration
TN2009000233A1 (en) Radiolabelling via fluorination of aziridines
MX2012001921A (es) Diastereomeros simples de 4-fluoroglutamina y metodos para su preparacion y uso.
WO2009013358A3 (fr) Nouvelles compositions à base de polysaccharides greffés avec des polyamines ou des composés polysulfurés
EP2099458A4 (fr) Composés et procédés pour imagerie et thérapie de tumeurs médiées par des enzymes
MX2011012602A (es) Proceso para la preparacion de un agente de yodatacion.
WO2009150139A3 (fr) Dérivés d’indolyl-pyridazinyl-diazabicyclononane sous forme marquée et non marquée et leur utilisation dans des procédés diagnostiques
SG178929A1 (en) Use of cathepsin h
EP1985624A3 (fr) Procédé simple de radiofluorination de composés actifs biologiquement ou de biomolécules
ZA200905541B (en) Radiolabelling via fluorination of aziridines
WO2009114742A3 (fr) Composés bisthiol stables pour la radio-imagerie et la radiothérapie